Day's Low
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -2.84 % |
3 Month Return | -12.7 % |
1 Year Return | -29.04 % |
Market Stats | |
Previous Close | ₹63.90 |
Open | ₹63.90 |
Volume | 15.39K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹132.91Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹132.91 Cr |
P/B Ratio | 1.98 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Healthcare |
ROE | 4.97 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹132.91 Cr | 33.89% | 0.51 | NA | NA | |
NA | ₹78.67 Cr | 37.94% | 0.56 | -₹2 Cr | ₹39 Cr | |
NA | ₹19.28 Cr | 18.02% | 0.60 | ₹4 Cr | ₹13 Cr | |
BUY | ₹5,136.73 Cr | 14.21% | 0.54 | ₹69 Cr | ₹571 Cr | |
BUY | ₹6,530.27 Cr | 65.89% | 0.70 | ₹41 Cr | ₹1,907 Cr |
Organisation | Lotus Eye Hospital & Institute Ltd |
Headquarters | |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Lotus Eye Hospital & Institute Ltd
Vice President of Administration, Rajkumar Sundaramoorthy, sold 92% of their holding in Lotus Eye Hospital and Institute for ₹173m. This is the biggest sale made by an insider individual in the last twelve months. While insider selling is not a positive sign, it's only a weak signal that insiders think shares are fully valued.
Lotus Eye-care Hospital and Institute Touches 52-Week Low - 05 Mar, 2024
High-frequency trading firms have been active in small, illiquid stocks like Lotus Eye-care Hospital and Institute, which touched a 52-week low.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 59.75% to 59.94% in Sep 2024 quarter
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 190.4% return, outperforming this stock by 146.9%
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 87.8% return, outperforming this stock by 116.8%
Promoter Holding Down
Promoters have decreased holdings from 40.24% to 40.03% in Sep 2024 quarter
Price Dip
In the last 1 year, LOTUSEYE stock has moved down by -29.0%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 40.03% | ||
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 59.94% | 0.31 | |
Others | 0.03% | 266.67 |
Lotus Eye Hospital & Institute Ltd’s net profit fell -88.24% since last year same period to ₹0.10Cr in the Q2 2024-2025. On a quarterly growth basis, Lotus Eye Hospital & Institute Ltd has generated -83.87% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2023, Lotus Eye Hospital & Institute Ltd has declared dividend of ₹0.50 - translating a dividend yield of 1.49%.
Read More about DividendsBearish
Neutral
Bullish
Lotus Eye Hospital & Institute Ltd is currently in a Bearish trading position according to technical analysis indicators.
Lotus Eye Hospital & Institute Ltd (LOTUSEYE) share price today is ₹67.09
Lotus Eye Hospital & Institute Ltd is listed on NSE
Lotus Eye Hospital & Institute Ltd is listed on BSE
Today’s traded volume of Lotus Eye Hospital & Institute Ltd(LOTUSEYE) is 15.39K.
Today’s market capitalisation of Lotus Eye Hospital & Institute Ltd(LOTUSEYE) is ₹132.91Cr.
Lotus Eye Hospital & Institute Ltd(LOTUSEYE | Price |
---|---|
52 Week High | ₹102 |
52 Week Low | ₹48.5 |
Lotus Eye Hospital & Institute Ltd(LOTUSEYE) share price is ₹67.09. It is down -34.23% from its 52 Week High price of ₹102
Lotus Eye Hospital & Institute Ltd(LOTUSEYE) share price is ₹67.09. It is up 38.33% from its 52 Week Low price of ₹48.5
Lotus Eye Hospital & Institute Ltd(LOTUSEYE | Returns |
---|---|
1 Day Returns | 3.19% |
1 Month Returns | -2.84% |
3 Month Returns | -12.7% |
1 Year Returns | -29.04% |